FDA OKs Return of Once-Withdrawn Leukemia Drug, Mylotarg

FRIDAY, Sept. 1, 2017 -- The U.S. Food and Drug Administration on Friday approved an altered dose of the drug Mylotarg to treat a distinctive type of acute myeloid leukemia -- CD33-positive AML. An earlier version of the drug had been withdrawn...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news